Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

Increased Plasma Urotensin-II and Carotid Atherosclerosis are Associated with Vascular Dementia

(2011) Yoshiyuki Ban et al.   Journal of Atherosclerosis and Thrombosis

Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

(2010) William T. Hu et al.   ACTA NEUROPATHOLOGICA

YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease

(2010) Rebecca Craig-Schapiro et al.   BIOLOGICAL PSYCHIATRY

Sparse partial least squares regression for simultaneous dimension reduction and variable selection

(2010) Hyonho Chun et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY

Unknown

(2010) Michael Bacher et al.   MOLECULAR MEDICINE

Fibrinogen and β-Amyloid Association Alters Thrombosis and Fibrinolysis: A Possible Contributing Factor to Alzheimer's Disease

(2010) Marta Cortes-Canteli et al.   NEURON

The FAS gene, brain volume, and disease progression in Alzheimer's disease

(2009) Deniz Erten-Lyons et al.   Alzheimers & Dementia

Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease

(2009) Anne M. Fagan et al.   EMBO Molecular Medicine

Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and β-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain

(2009) Susanne Bürger et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE

Increase of SCF plasma concentration during donepezil treatment of patients with early Alzheimer's disease

(2009) Thomas Leyhe et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain

(2009) Shay Fabbro et al.   JOURNAL OF NEUROCHEMISTRY

Alzheimer’s β-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2

(2009) Nikunj S. Patel et al.   JOURNAL OF NEUROCHEMISTRY

VEGF genetic variability is associated with increased risk of developing Alzheimer's disease

(2009) Roberto Del Bo et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

(2009) Richard J. Perrin et al.   NATURE

Relationships between biomarkers in aging and dementia

(2009) W. J. Jagust et al.   NEUROLOGY

Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease

(2009) Peder Buchhave et al.   PLoS One

Age-related differences in NFκB translocation and Bcl-2/Bax ratio caused by TNFα and Abeta42 promote survival in middle-age neurons and death in old neurons

(2008) Jigisha R. Patel et al.   EXPERIMENTAL NEUROLOGY

Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer’s disease

(2008) Julius Popp et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Biomarkers of Alzheimer's disease

(2008) Rebecca Craig-Schapiro et al.   NEUROBIOLOGY OF DISEASE

Serum cystatin C and the risk of Alzheimer disease in elderly men

(2008) J. Sundelof et al.   NEUROLOGY

Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study

(2008) O. L. Lopez et al.   NEUROLOGY

Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease

(2007) Harald Hampel et al.   Alzheimers & Dementia

Increasing CSF phospho-tau levels during cognitive decline and progression to dementia

(2007) Christin Andersson et al.   NEUROBIOLOGY OF AGING